Literature DB >> 22770980

Translocations disrupting PHF21A in the Potocki-Shaffer-syndrome region are associated with intellectual disability and craniofacial anomalies.

Hyung-Goo Kim1, Hyun-Taek Kim, Natalia T Leach, Fei Lan, Reinhard Ullmann, Asli Silahtaroglu, Ingo Kurth, Anja Nowka, Ihn Sik Seong, Yiping Shen, Michael E Talkowski, Douglas Ruderfer, Ji-Hyun Lee, Caron Glotzbach, Kyungsoo Ha, Susanne Kjaergaard, Alex V Levin, Bernd F Romeike, Tjitske Kleefstra, Oliver Bartsch, Sarah H Elsea, Ethylin Wang Jabs, Marcy E MacDonald, David J Harris, Bradley J Quade, Hans-Hilger Ropers, Lisa G Shaffer, Kerstin Kutsche, Lawrence C Layman, Niels Tommerup, Vera M Kalscheuer, Yang Shi, Cynthia C Morton, Cheol-Hee Kim, James F Gusella.   

Abstract

Potocki-Shaffer syndrome (PSS) is a contiguous gene disorder due to the interstitial deletion of band p11.2 of chromosome 11 and is characterized by multiple exostoses, parietal foramina, intellectual disability (ID), and craniofacial anomalies (CFAs). Despite the identification of individual genes responsible for multiple exostoses and parietal foramina in PSS, the identity of the gene(s) associated with the ID and CFA phenotypes has remained elusive. Through characterization of independent subjects with balanced translocations and supportive comparative deletion mapping of PSS subjects, we have uncovered evidence that the ID and CFA phenotypes are both caused by haploinsufficiency of a single gene, PHF21A, at 11p11.2. PHF21A encodes a plant homeodomain finger protein whose murine and zebrafish orthologs are both expressed in a manner consistent with a function in neurofacial and craniofacial development, and suppression of the latter led to both craniofacial abnormalities and neuronal apoptosis. Along with lysine-specific demethylase 1 (LSD1), PHF21A, also known as BHC80, is a component of the BRAF-histone deacetylase complex that represses target-gene transcription. In lymphoblastoid cell lines from two translocation subjects in whom PHF21A was directly disrupted by the respective breakpoints, we observed derepression of the neuronal gene SCN3A and reduced LSD1 occupancy at the SCN3A promoter, supporting a direct functional consequence of PHF21A haploinsufficiency on transcriptional regulation. Our finding that disruption of PHF21A by translocations in the PSS region is associated with ID adds to the growing list of ID-associated genes that emphasize the critical role of transcriptional regulation and chromatin remodeling in normal brain development and cognitive function.
Copyright © 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22770980      PMCID: PMC3397276          DOI: 10.1016/j.ajhg.2012.05.005

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  73 in total

1.  Identification of loci associated with schizophrenia by genome-wide association and follow-up.

Authors:  Michael C O'Donovan; Nicholas Craddock; Nadine Norton; Hywel Williams; Timothy Peirce; Valentina Moskvina; Ivan Nikolov; Marian Hamshere; Liam Carroll; Lyudmila Georgieva; Sarah Dwyer; Peter Holmans; Jonathan L Marchini; Chris C A Spencer; Bryan Howie; Hin-Tak Leung; Annette M Hartmann; Hans-Jürgen Möller; Derek W Morris; Yongyong Shi; GuoYin Feng; Per Hoffmann; Peter Propping; Catalina Vasilescu; Wolfgang Maier; Marcella Rietschel; Stanley Zammit; Johannes Schumacher; Emma M Quinn; Thomas G Schulze; Nigel M Williams; Ina Giegling; Nakao Iwata; Masashi Ikeda; Ariel Darvasi; Sagiv Shifman; Lin He; Jubao Duan; Alan R Sanders; Douglas F Levinson; Pablo V Gejman; Sven Cichon; Markus M Nöthen; Michael Gill; Aiden Corvin; Dan Rujescu; George Kirov; Michael J Owen; Nancy G Buccola; Bryan J Mowry; Robert Freedman; Farooq Amin; Donald W Black; Jeremy M Silverman; William F Byerley; C Robert Cloninger
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

2.  Rare chromosomal deletions and duplications increase risk of schizophrenia.

Authors: 
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

3.  Genomewide association for schizophrenia in the CATIE study: results of stage 1.

Authors:  P F Sullivan; D Lin; J-Y Tzeng; E van den Oord; D Perkins; T S Stroup; M Wagner; S Lee; F A Wright; F Zou; W Liu; A M Downing; J Lieberman; S L Close
Journal:  Mol Psychiatry       Date:  2008-03-18       Impact factor: 15.992

4.  Disruption of neurexin 1 associated with autism spectrum disorder.

Authors:  Hyung-Goo Kim; Shotaro Kishikawa; Anne W Higgins; Ihn-Sik Seong; Diana J Donovan; Yiping Shen; Eric Lally; Lauren A Weiss; Juliane Najm; Kerstin Kutsche; Maria Descartes; Lynn Holt; Stephen Braddock; Robin Troxell; Lee Kaplan; Fred Volkmar; Ami Klin; Katherine Tsatsanis; David J Harris; Ilse Noens; David L Pauls; Mark J Daly; Marcy E MacDonald; Cynthia C Morton; Bradley J Quade; James F Gusella
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

5.  Genome-wide association study of bipolar disorder in European American and African American individuals.

Authors:  E N Smith; C S Bloss; J A Badner; T Barrett; P L Belmonte; W Berrettini; W Byerley; W Coryell; D Craig; H J Edenberg; E Eskin; T Foroud; E Gershon; T A Greenwood; M Hipolito; D L Koller; W B Lawson; C Liu; F Lohoff; M G McInnis; F J McMahon; D B Mirel; S S Murray; C Nievergelt; J Nurnberger; E A Nwulia; J Paschall; J B Potash; J Rice; T G Schulze; W Scheftner; C Panganiban; N Zaitlen; P P Zandi; S Zöllner; N J Schork; J R Kelsoe
Journal:  Mol Psychiatry       Date:  2009-06-02       Impact factor: 15.992

6.  FISH mapping of de novo apparently balanced chromosome rearrangements identifies characteristics associated with phenotypic abnormality.

Authors:  J A Fantes; E Boland; J Ramsay; D Donnai; M Splitt; J A Goodship; H Stewart; M Whiteford; P Gautier; L Harewood; S Holloway; F Sharkey; E Maher; V van Heyningen; J Clayton-Smith; D R Fitzpatrick; G C M Black
Journal:  Am J Hum Genet       Date:  2008-03-27       Impact factor: 11.025

7.  Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression.

Authors:  Fei Lan; Robert E Collins; Rossella De Cegli; Roman Alpatov; John R Horton; Xiaobing Shi; Or Gozani; Xiaodong Cheng; Yang Shi
Journal:  Nature       Date:  2007-08-09       Impact factor: 49.962

8.  Characterization of apparently balanced chromosomal rearrangements from the developmental genome anatomy project.

Authors:  Anne W Higgins; Fowzan S Alkuraya; Amy F Bosco; Kerry K Brown; Gail A P Bruns; Diana J Donovan; Robert Eisenman; Yanli Fan; Chantal G Farra; Heather L Ferguson; James F Gusella; David J Harris; Steven R Herrick; Chantal Kelly; Hyung-Goo Kim; Shotaro Kishikawa; Bruce R Korf; Shashikant Kulkarni; Eric Lally; Natalia T Leach; Emma Lemyre; Janine Lewis; Azra H Ligon; Weining Lu; Richard L Maas; Marcy E MacDonald; Steven D P Moore; Roxanna E Peters; Bradley J Quade; Fabiola Quintero-Rivera; Irfan Saadi; Yiping Shen; Jay Shendure; Robin E Williamson; Cynthia C Morton
Journal:  Am J Hum Genet       Date:  2008-03       Impact factor: 11.025

9.  Mapping translocation breakpoints by next-generation sequencing.

Authors:  Wei Chen; Vera Kalscheuer; Andreas Tzschach; Corinna Menzel; Reinhard Ullmann; Marcel Holger Schulz; Fikret Erdogan; Na Li; Zofia Kijas; Ger Arkesteijn; Isidora Lopez Pajares; Margret Goetz-Sothmann; Uwe Heinrich; Imma Rost; Andreas Dufke; Ute Grasshoff; Birgitta Glaeser; Martin Vingron; H Hilger Ropers
Journal:  Genome Res       Date:  2008-03-07       Impact factor: 9.043

10.  Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder.

Authors:  Manuel A R Ferreira; Michael C O'Donovan; Yan A Meng; Ian R Jones; Douglas M Ruderfer; Lisa Jones; Jinbo Fan; George Kirov; Roy H Perlis; Elaine K Green; Jordan W Smoller; Detelina Grozeva; Jennifer Stone; Ivan Nikolov; Kimberly Chambert; Marian L Hamshere; Vishwajit L Nimgaonkar; Valentina Moskvina; Michael E Thase; Sian Caesar; Gary S Sachs; Jennifer Franklin; Katherine Gordon-Smith; Kristin G Ardlie; Stacey B Gabriel; Christine Fraser; Brendan Blumenstiel; Matthew Defelice; Gerome Breen; Michael Gill; Derek W Morris; Amanda Elkin; Walter J Muir; Kevin A McGhee; Richard Williamson; Donald J MacIntyre; Alan W MacLean; Clair David St; Michelle Robinson; Margaret Van Beck; Ana C P Pereira; Radhika Kandaswamy; Andrew McQuillin; David A Collier; Nicholas J Bass; Allan H Young; Jacob Lawrence; I Nicol Ferrier; Adebayo Anjorin; Anne Farmer; David Curtis; Edward M Scolnick; Peter McGuffin; Mark J Daly; Aiden P Corvin; Peter A Holmans; Douglas H Blackwood; Hugh M Gurling; Michael J Owen; Shaun M Purcell; Pamela Sklar; Nick Craddock
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

View more
  36 in total

Review 1.  KDM1 class flavin-dependent protein lysine demethylases.

Authors:  Jonathan M Burg; Jennifer E Link; Brittany S Morgan; Frederick J Heller; Amanda E Hargrove; Dewey G McCafferty
Journal:  Biopolymers       Date:  2015-07       Impact factor: 2.505

Review 2.  Yin-yang actions of histone methylation regulatory complexes in the brain.

Authors:  Patricia Marie Garay; Margarete Aryanka Wallner; Shigeki Iwase
Journal:  Epigenomics       Date:  2016-11-18       Impact factor: 4.778

3.  The Genetic Control of Stoichiometry Underlying Autism.

Authors:  Robert B Darnell
Journal:  Annu Rev Neurosci       Date:  2020-07-08       Impact factor: 12.449

Review 4.  Toward development of epigenetic drugs for central nervous system disorders: Modulating neuroplasticity via H3K4 methylation.

Authors:  Emily L Ricq; Jacob M Hooker; Stephen J Haggarty
Journal:  Psychiatry Clin Neurosci       Date:  2016-09-07       Impact factor: 5.188

Review 5.  Enhancers: bridging the gap between gene control and human disease.

Authors:  Jaret M Karnuta; Peter C Scacheri
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

Review 6.  Disrupted intricacy of histone H3K4 methylation in neurodevelopmental disorders.

Authors:  Christina N Vallianatos; Shigeki Iwase
Journal:  Epigenomics       Date:  2015       Impact factor: 4.778

7.  A de novo t(10;19)(q22.3;q13.33) leads to ZMIZ1/PRR12 reciprocal fusion transcripts in a girl with intellectual disability and neuropsychiatric alterations.

Authors:  Carlos Córdova-Fletes; Ma Guadalupe Domínguez; Ilse Delint-Ramirez; Herminia G Martínez-Rodríguez; Ana María Rivas-Estilla; Patricio Barros-Núñez; Rocío Ortiz-López; Vivian Alejandra Neira
Journal:  Neurogenetics       Date:  2015-07-11       Impact factor: 2.660

8.  Transcriptome Analysis Revealed Impaired cAMP Responsiveness in PHF21A-Deficient Human Cells.

Authors:  Robert S Porter; Yumie Murata-Nakamura; Hajime Nagasu; Hyung-Goo Kim; Shigeki Iwase
Journal:  Neuroscience       Date:  2017-05-29       Impact factor: 3.590

9.  De novo truncating variants in PHF21A cause intellectual disability and craniofacial anomalies.

Authors:  Kohei Hamanaka; Yuji Sugawara; Takeyoshi Shimoji; Tone Irene Nordtveit; Mitsuhiro Kato; Mitsuko Nakashima; Hirotomo Saitsu; Toshimitsu Suzuki; Kazuhiro Yamakawa; Ingvild Aukrust; Gunnar Houge; Satomi Mitsuhashi; Atsushi Takata; Kazuhiro Iwama; Ahmed Alkanaq; Atsushi Fujita; Eri Imagawa; Takeshi Mizuguchi; Noriko Miyake; Satoko Miyatake; Naomichi Matsumoto
Journal:  Eur J Hum Genet       Date:  2018-11-28       Impact factor: 4.246

Review 10.  From neural development to cognition: unexpected roles for chromatin.

Authors:  Jehnna L Ronan; Wei Wu; Gerald R Crabtree
Journal:  Nat Rev Genet       Date:  2013-04-09       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.